2017 ISAKOS Biennial Congress Faculty

 

James Chow, MD

Chow Surgical, LLC | Inkwell Health, Ltd
Phoenix, AZ UNITED STATES

Dr. Jimmy Chow is a surgeon-inventor, with over 20 patents worldwide in the US, Canada, EU, Australia, Japan & China. He is an engineer and a board-certified hip and knee specialist with dual-fellowship training in Adult Reconstruction and Arthroscopic Surgery. Dr. Chow is the emeritus National Medical Director of Orthopaedics for Tenet Healthcare, the 3rd largest for-profit hospital system in the US. He is the founder of Chow Surgical LLC in Phoenix, AZ, where he is the Fellowship Director for an ISAKOS-accredited fellowship in hip & knee surgery. He has extensive experience with surgical technology and has been involved with orthopedics robotics platforms since 2010. He lectures on data, technology, robotics, and AI, and most recently helped introduce the world’s first machine-learning AI system in orthopedic surgery. Dr. Chow is credited as a key inventor of the SuperPATH microinvasive total hip procedure and has been a lead designing surgeon for the NAVIO and CORI robotics platforms. Dr. Chow has recently founded and launched Inkwell Health, a computer-vision modeling technology using legacy cell phone cameras and temporary tattoos to provide real-time remote patient monitoring data. For more info, see https://inkwellhealth.com/
http://www.ChowHipAndKnee.com

Tue 06/06
17:15 - 17:20
Room 2-3: Concurrent 3 Knee - Arthroplasty
Paper
The Use of Intraoperative Sensors Significantly Increases the Patient-Reported Rate of Improvement in Primary TKA
Presenting Author

Disclosures

Royalties received from Microport Orthopedics, Inc., Smith & Nephew, Stryker
Speaker for Microport Orthopedics, Smith & Nephew
Paid Consultant for Microport Orthopedics, Smith & Nephew, Vomaris Innovations, Inc.
Stock received from Axolotl Biologix, InkWell Health, Pfizer, Stryker, Vomaris Innovations, Inc.
Support received from Microport Orthopedics, Inc., Smith & Nephew, Vomaris Innovations
Board of Directors member for Chow Research Foundation

All relevant financial disclosures have been mitigated.